<DOC>
	<DOC>NCT02853916</DOC>
	<brief_summary>The objectives of this trial are to confirm efficacy in human of a brown seaweed powder and explore dose-response relationship by comparing two different doses. The primary endpoint is incremental area under the curve (iAUC, mmol*min/L) for blood glucose.</brief_summary>
	<brief_title>Efficacy of a Brown Seaweed Powder for Glycemic Control</brief_title>
	<detailed_description />
	<criteria>Males and females aged between 1845 y Normoglycemic (fasting blood glucose &lt;5.6 mmol/L) Body mass index (BMI) 18.529.9 kg/m2 Able to consume bread products Exclusion Criteria Fasting blood glucose &gt; 5.6 mmol/L Systolic blood pressure &gt; 140 mmHg and/or diastolic blood pressure &gt; 90 mmHg Previous history of cardiovascular disease, diabetes, liver or kidney disease, inflammatory bowel disease, celiac disease, short bowel syndrome, any malabsorptive syndrome, pancreatitis, gallbladder or biliary disease Presence of a gastrointestinal disorder within the past year Presence of major gastrointestinal surgeries Thyroid problems Smokers Consuming prescription or nonprescription drug, herbal or nutritional supplements known to affect blood glucose or that could affect the outcome of the study as per investigator's judgement Women that are currently pregnant or lactating, or not using an appropriate contraception method Excessive alcohol intake (more than 2 drinks per day or more than 9 drinks per week) Allergic to shellfish (crab) or molluscs Weight gain or loss of at least 10lbs in previous three months</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>